We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
N4 Pharma Plc | LSE:N4P | London | Ordinary Share | GB00BYW8QM32 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.05 | -6.06% | 0.775 | 0.75 | 0.80 | 0.825 | 0.775 | 0.83 | 611,345 | 15:32:48 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Drug & Proprietary Stores | 0 | -1.03M | -0.0057 | -1.35 | 1.39M |
Date | Subject | Author | Discuss |
---|---|---|---|
23/4/2018 13:53 | Double bottom and a nice reversal lovely jubbly | jakleeds | |
20/4/2018 15:14 | You lads get far too excited about a 1.7% rise.. | dplewis1 | |
20/4/2018 12:44 | N I C E !!!! | escapetohome | |
20/4/2018 08:47 | Hitting base, this should be up over 30p:) | ch1rp | |
19/4/2018 13:31 | Yes I think there is little doubt it works as a drug. And as per the RNS the trials are also about measuring the concentration in blood over a period of time for fed and fasted. This is key scientific data required for regulatory discussions pre phase 3 as well as showing to potential partners it is really effective. | toadhall1 | |
19/4/2018 13:15 | Maybe Jak, but they are not going to say officially ;-)A new drug has around a 4% chance of making it to market. A reformulation around 80-90% IIRC? | tp6 | |
19/4/2018 11:14 | Surely some of the directors/employees will have tried it and know if it works ?? | jakleeds | |
19/4/2018 08:51 | Not a chance im selling at 20 p. This will be higher if trials successful. | escapetohome | |
19/4/2018 08:49 | @flashheart ..Lol indeed. "I present to you a buying opportunity.." | dplewis1 | |
18/4/2018 21:02 | hTTps://uk.webfg.com | parob | |
18/4/2018 14:10 | N4 on twitter:Delighted to be shortlisted as a finalist in the start up category for the @medilinkem Business Awards #n4pIt's like waiting for a bus... #nuvec also shortlisted as a finalist for the @MedilinkEM Business Awards in the Innovation category #n4p | parob | |
18/4/2018 09:37 | Nothing a sure thing on AIM, but good to see they are progressing well and there appears to be a good chance of success, he solution is simple but the manufacture for testing will need to be spot on. | urigem | |
18/4/2018 08:38 | Ok thanks for the responses. As far as clinical trials go I don't suppose they were too short of applicants. I wonder if they give them any assistance in getting it to wear off or if there are a dozen blokes walking round Derby knocking holes in cheap doors? | dplewis1 | |
18/4/2018 08:36 | Yes, these are not complex mechanisms of action, so I would not expect poor results. These actions are used for other drugs, albeit not together. The beauty with N4s version is it's complex simplicity, pure genius | trotterstrading | |
18/4/2018 08:31 | Don’t want to speculate but my guess is that they are confident it works. The question is whether or not it needs tweaking before it comes to market: The data gathered from the Trial will enable the Company to establish whether its reformulation has been sufficiently successful to allow N4 Pharma to prepare for a pre-IND meeting with the FDA towards the end of this year or whether further amendments to the reformulation may be required to optimise efficacy. | jakleeds | |
18/4/2018 08:27 | All we need now is some good Nuvec news and we will be on to new highs. | parob | |
18/4/2018 08:17 | From John on lse : The tab has a soluble outer coating (quick release component) which dissolves in the mouth before swallowing the inner core for the slow release. Nov prezzo gives full details. | jakleeds | |
18/4/2018 08:17 | N4's sildenafil has outer and inner coating as far as I'm aware | parob | |
18/4/2018 08:16 | Can someone with a better knowledge of clinical trials explain to me why they compare 100mg of Sildenafil against 50mg of viagra? Not a loaded question before anyone gets all uppity, just want to understand how the trial will be performed. | dplewis1 | |
18/4/2018 08:12 | In the meantime, the market had reacted positively to this morning’s statement. Lovely stuff | jakleeds | |
18/4/2018 08:11 | Haha. I’m not pretending anything Jim. I posted the info that was available late at that time, as I did again this morning. | jakleeds | |
18/4/2018 08:03 | Jak, it was you on the 27th March who posted this.. "The Pilot Trial is due to take place in early 2018 with results expected by the end of April 2018." So don't pretend you knew any different. | jimbobaroony | |
18/4/2018 07:57 | Exactly Urigem. And let’s not forget , Nuvec updates could come at any time ... | jakleeds |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions